10-Q: Forward Industries Reports Q2 2025 Results: Revenue Declines, Strategic Shift Underway

Sentiment:

Quarterly Report


Forward Industries reports a net loss for Q2 2025, driven by decreased revenue and a strategic shift involving the discontinuation of the OEM distribution segment.

Capital raiseThe Company is currently in preliminary discussions regarding a potential sale of equity securities and establishment of an equity line of credit facility with an institutional investor.We can provide no assurance that either financing will close or, if closed, will be on terms acceptable to us.
Worse than expectedThe company reported a larger net loss compared to the same period last year.Revenue decreased significantly due to the loss of a major customer and decreased project volume.Gross profit margin declined substantially.

Summary

  • Forward Industries reported a net loss of $1.45 million for the three months ended March 31, 2025, and a net loss of $2.16 million for the six months ended March 31, 2025.
  • Revenue decreased to $3.12 million for the quarter and $7.75 million for the six-month period, primarily due to the loss of a major customer and decreased project volume.
  • The company is discontinuing its OEM distribution segment and plans to sell it within the next three months.
  • The company's design segment remains its only reportable segment.
  • The company's largest design customer discontinued their insulin patch pump program, which is expected to cause a material decrease in revenues.
  • The company is in preliminary discussions regarding a potential sale of equity securities and establishment of an equity line of credit facility with an institutional investor.
  • There is substantial doubt about the company's ability to continue as a going concern for the next 12 months.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to decreased revenue, net losses, and concerns about the company's ability to continue as a going concern. However, the company is taking steps to address these challenges, such as cost reduction efforts and exploring potential financing options.

Positives

  • The company is actively pursuing cost reduction efforts to mitigate the impact of decreased revenue.
  • The company is in preliminary discussions regarding a potential sale of equity securities and establishment of an equity line of credit facility with an institutional investor.
  • General and administrative expenses decreased in the 2025 Quarter and Period.
  • The company regained compliance with Nasdaq listing standards in March 2025.

Negatives

  • The company reported a significant net loss for both the three and six months ended March 31, 2025.
  • Revenue decreased significantly due to the loss of a major customer and decreased project volume.
  • Gross profit margin declined substantially.
  • The company recorded a goodwill impairment charge of $225,000.
  • There is substantial doubt about the company's ability to continue as a going concern.

Risks

  • The company's ability to continue as a going concern is uncertain.
  • The loss of a major customer will continue to negatively impact revenue.
  • The company may not be able to successfully sell its OEM distribution segment.
  • The company may not be able to secure additional financing on acceptable terms.
  • The company's stock is subject to a Nasdaq Panel Monitor until July 24, 2025, which could lead to delisting if the company fails to meet the Stockholders Equity Rule.

Future Outlook

The company expects a material decrease in design segment revenues in Fiscal 2025 due to the loss of a major customer. The company is working on cost reduction efforts to mitigate the reduction in revenue. The company believes that its revenues will continue to decrease in the design business as customers are slow to commit funds to projects.

Industry Context

The company operates in the global design, sourcing, and distribution industry, serving top-tier medical and technology customers. The loss of a major customer and the uncertainty in the global markets related to tariffs on imports are impacting the company's performance. The company's strategic shift to discontinue its OEM distribution segment reflects a broader trend of companies focusing on core competencies and streamlining operations.

Comparison to Industry Standards

  • It is difficult to compare Forward Industries directly to industry standards due to its unique combination of design, sourcing, and distribution activities.
  • However, companies like Flex Ltd. and Jabil Inc. are major players in the design and manufacturing services industry, and their financial performance can provide some context.
  • These companies typically have higher revenue and profitability due to their scale and diversified customer base.
  • Forward Industries' reliance on a few large customers makes it more vulnerable to customer-specific risks compared to these larger, more diversified companies.

Related Party Transactions

  • The company has a Buying Agency and Supply Agreement with Forward China, a related party owned by the company's CEO.
  • The company entered into four separate agreements with Forward China to convert an aggregate $4,925,000 of amounts Due to Forward China into shares of Series A-1 Convertible Preferred Stock.
  • The company has a $600,000 unsecured promissory note payable to Forward China.
  • The company recorded revenue from a customer whose principal owner is an immediate family member of Jenny P. Yu, a significant shareholder of the Company and managing director of Forward China.

Stakeholder Impact

  • Shareholders will be negatively impacted by the decreased revenue, net losses, and concerns about the company's ability to continue as a going concern.
  • Employees may be impacted by cost reduction efforts and the sale of the OEM distribution segment.
  • Customers may be impacted by the company's strategic shift and the loss of a major customer.
  • Suppliers may be impacted by the company's financial challenges and the sale of the OEM distribution segment.
  • Creditors may be concerned about the company's ability to repay its debts.

Next Steps

  • The company plans to sell its OEM distribution segment within the next three months.
  • The company is in preliminary discussions regarding a potential sale of equity securities and establishment of an equity line of credit facility with an institutional investor.
  • Management will continue to evaluate cost reduction efforts as needed.
  • The company intends to fund the repayment of the $600,000 promissory note at maturity using existing cash balances, proceeds from equity and/or debt financing, and/or by seeking additional extensions as deemed necessary.

Key Dates

DateDescription
2018-01-18Company issued a $1,600,000 unsecured promissory note payable to Forward China to fund the acquisition of IPS.
2023-07Company decided to cease operations of its retail distribution segment (Retail Exit).
2023-10-30Forward China agreed to limit the amount of outstanding payables it would seek to collect from the Company to $500,000 in any 12-month period.
2024-06-18A 1-for-10 reverse stock split of common stock became effective.
2024-12IPS was notified by its largest customer of its plan to discontinue its insulin patch pump program.
2025-03Company committed to a plan to sell the original equipment manufacturer (OEM) distribution segment of the business.
2025-03-31End of the quarterly period.
2025-04-30Buying Agency and Supply Agreement was scheduled to expire.
2025-06-30Maturity date of the $600,000 promissory note payable to Forward China.
2025-07-24End date of the Nasdaq Panel Monitor.

Keywords

Forward Industries, financial results, OEM distribution segment, design segment, revenue decline, net loss, going concern, liquidity, Nasdaq, related party transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.